PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.
- DOI
- 10.1038/s41380-026-03740-y
- Published
- 2026 Jul 13
- Container
- Molecular psychiatry
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41380-026-03740-y,
title = {PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.},
author = {Qiu Y and Wu S and Zhong Y and Fan D and Tong Q and Xiong J and Xu K and Liu G and Liu E and Li X and Huang K},
year = {2026},
journal = {Molecular psychiatry},
doi = {10.1038/s41380-026-03740-y},
url = {https://doi.org/10.1038/s41380-026-03740-y}
}RIS
TY - JOUR TI - PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models. AU - Qiu Y AU - Wu S AU - Zhong Y AU - Fan D AU - Tong Q AU - Xiong J AU - Xu K AU - Liu G AU - Liu E AU - Li X AU - Huang K PY - 2026 JO - Molecular psychiatry DO - 10.1038/s41380-026-03740-y UR - https://doi.org/10.1038/s41380-026-03740-y ER -
APA
Y, Q., S, W., Y, Z., D, F., Q, T., J, X., K, X., G, L., E, L., X, L., & K, H. (2026). PIAS1-mediated GSK3β SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models.. Molecular psychiatry. https://doi.org/10.1038/s41380-026-03740-y
Source records
- pubmed · retrieved 2026-09-25T16:54:08.699Z
- europe-pmc · retrieved 2026-09-25T16:54:08.708Z